GANX
Gain Therapeutics Inc
1.80$
-3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 6,886.4% | 6,383.9% | 10,675.3% | 26,978.7% | 2,011.3% | 9,057.4% | 3,407.9% | 3,458.3% | 2,715.2% | – | 12.9% | 4,995.1% | – | – | 36.4% | – | – | – | 25.9% | – | – | – | – | – | – | – | |
| – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | -12.9% | 100.0% | – | – | -36.4% | – | – | – | -25.9% | – | – | – | – | – | – | – | |
| 4,012.2% | 4,012.4% | 4,012.4% | 4,012.4% | 3,840.7% | 3,840.8% | 3,840.8% | 3,840.8% | – | 6,252.9% | 6,886.4% | 6,383.9% | 10,675.3% | 26,978.7% | 2,011.3% | 9,057.4% | 3,407.9% | 3,458.3% | 2,715.2% | – | 1,622.9% | 5,058.4% | – | – | 3,663.6% | – | – | – | 1,489.3% | – | – | – | – | – | – | – | |
| 1,077.4% | 1,077.5% | 1,077.5% | 1,077.5% | 1,344.2% | 1,344.2% | 1,344.2% | 1,344.2% | – | 1,523.7% | 1,568.6% | 5,948.6% | 7,103.2% | 19,940.7% | 2,030.0% | 7,996.1% | 4,118.5% | 3,948.5% | 2,827.8% | – | 1,632.6% | 4,519.3% | – | – | 3,137.7% | – | – | – | 2,561.1% | – | – | – | – | – | – | – | |
| – | -5,089.9% | -5,089.9% | -5,089.9% | – | -5,185.0% | -5,185.0% | -5,185.0% | – | 7,776.6% | 8,455.0% | 12,332.5% | 17,778.5% | 46,919.4% | 4,041.3% | 17,053.5% | 7,526.3% | 7,406.8% | 5,543.0% | – | 3,255.5% | 9,577.7% | – | – | 6,801.3% | – | – | – | 4,050.4% | – | – | – | – | – | – | – | |
| -4,989.7% | -4,989.9% | -4,989.9% | -4,989.9% | -5,084.9% | -5,085.0% | -5,085.0% | -5,085.0% | – | -7,676.6% | -8,355.0% | -12,232.5% | -17,678.5% | -46,819.4% | -3,941.3% | -16,953.5% | -7,426.3% | -7,306.8% | -5,443.0% | – | -3,255.5% | -9,477.7% | – | – | -6,801.3% | – | – | – | -4,050.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 26.2% | 23.8% | 0.1% | – | 26.7% | 6.6% | 18.0% | – | 3.7% | 63.0% | – | 151.0% | 275.5% | – | – | 234.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -5,316.9% | -5,317.1% | -5,317.1% | -5,317.1% | -5,293.7% | -5,293.8% | -5,293.8% | -5,293.8% | – | -8,735.5% | -8,455.0% | -11,850.1% | -18,131.6% | -46,440.8% | -3,984.4% | -17,035.7% | -7,471.2% | -7,267.8% | -5,337.7% | – | -3,280.6% | -9,279.8% | – | – | -7,267.7% | – | – | – | -3,968.2% | – | – | – | – | – | – | – | |
| 47.5% | 47.5% | 47.5% | 47.5% | 17.2% | 17.2% | 17.2% | 17.2% | – | 20.2% | 71.0% | 13.2% | -15.0% | 66.0% | 4.1% | 18.7% | -19.1% | 3.7% | 9.6% | – | 55.7% | 30.3% | – | – | 22.4% | – | – | – | 613.7% | – | – | – | – | – | – | – | |
| -5,364.4% | -5,364.6% | -5,364.6% | -5,364.6% | -5,310.9% | -5,311.0% | -5,311.0% | -5,311.0% | – | -8,755.7% | -8,526.0% | -11,863.4% | -18,116.7% | -46,506.9% | -3,988.5% | -17,054.4% | -7,452.2% | -7,271.6% | -5,347.3% | – | -3,336.3% | -9,310.1% | – | – | -7,290.1% | – | – | – | -4,581.9% | – | – | – | – | – | – | – | |
| -5,313.3% | 3.6% | 3.6% | 3.6% | -5,287.4% | 6.2% | 6.2% | 6.2% | – | -7,645.1% | -8,319.3% | -12,197.0% | -17,647.5% | -46,754.8% | -3,982.0% | -17,020.6% | -7,457.9% | -7,245.9% | -5,316.7% | – | -3,267.7% | -9,244.9% | – | – | -7,231.3% | – | – | – | -3,942.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.